Market open

Carl Zeiss Meditec/€AFX

08:00

10:10

12:15

14:25

16:30

1D1W1MYTD1Y5YMAX

About Carl Zeiss Meditec

Carl Zeiss Meditec AG, publicly traded under the ticker symbol AFX, specializes in the healthcare technology sector. Founded in 2002 as a spin-off from Carl Zeiss AG, it provides comprehensive medical solutions for ophthalmology and microsurgery. Operating globally, the company combines its expertise in optics, electronics, and precision engineering to offer innovative products that enhance patient care and clinical outcomes.

Ticker

€AFX

Sector

Health Care

Trading on

XETRA

Industry

Health Care Equipment & Supplies

Headquarters

Jena, Germany

Employees

5,730

Website

www.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

AFX Metrics

BasicAdvanced

€3.9B

22.43 €2.01

1.04 €1.10

2.44%

Price and volume

Market cap

€3.9B

Beta

1.04

52-week high

€70.05

52-week low

€44.74

Average daily volume

246K

Dividend rate

€1.10

Financial strength

Current ratio

2.132

Quick ratio

1.06

Long term debt to equity

25.615

Total debt to equity

26.931

Dividend payout ratio (TTM)

54.95%

Interest coverage (TTM)

6.37%

Management effectiveness

Return on assets (TTM)

3.65%

Return on equity (TTM)

8.52%

Valuation

Price to earnings (TTM)

22.431

Price to revenue (TTM)

1.94

Price to book

1.93

Price to tangible book (TTM)

5.21

Price to free cash flow (TTM)

42.149

Dividend yield (TTM)

2.44%

Forward dividend yield

2.44%

Growth

Revenue change (TTM)

-1.11%

Earnings per share change (TTM)

-38.05%

3-year revenue growth (CAGR)

7.85%

3-year earnings per share growth (CAGR)

-8.68%

3-year dividend per share growth (CAGR)

-12.64%

What the Analysts think about AFX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Carl Zeiss Meditec stock.

AFX Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

AFX Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe

Buy €AFX

€

Capital at risk

Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Carl Zeiss Meditec stock?

Carl Zeiss Meditec (AFX) has a market cap of €3.9B as of January 15, 2025.

What is the P/E ratio for Carl Zeiss Meditec stock?

The price to earnings (P/E) ratio for Carl Zeiss Meditec (AFX) stock is 22.43 as of January 15, 2025.

Does Carl Zeiss Meditec stock pay dividends?

Yes, the Carl Zeiss Meditec (AFX) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is €1.1 and the yield is 2.44%. Carl Zeiss Meditec has a payout ratio of 54.95% on a trailing twelve-month basis.

When is the next Carl Zeiss Meditec dividend payment date?

The next Carl Zeiss Meditec (AFX) dividend payment date is unconfirmed.

What is the beta indicator for Carl Zeiss Meditec?

Carl Zeiss Meditec (AFX) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.